Skip to main content
. 2004 Mar 2;90(5):1030–1033. doi: 10.1038/sj.bjc.6601647

Table 1. Clinicopathological features and methylation status of CDH13 promoter region in colorectal cancer patients.

  No. of cases CDH13 methylation
 
Clinicopathological variable features   + P-value
Sex
Male 45 18 27 0.098a
Female 39 9 30  
 
Maximal tumour size
15–100 mm 84 50.9±21.3b 45.2±16.5 0.182c
 
Histology
Poorly differentiatedd 6 5 1 0.0053a
Other differentiatede 78 22 56  
 
Extent of tumour
≦mtf 20 6 14 0.814a
mt< 64 21 43  
 
Lymph node metastasis
+ 31 6 25 0.055a
53 21 32  
 
Dukes' stage
A, B 54 19 35 0.423a
C, D 30 8 22  
 
Total 84 27 57  
a

χ2 test.

b

Mean±s.d.

c

Student's t-test.

d

Poorly differentiated or mucinous adenocarcinoma according to Japanese criteria.

e

Well- or moderately differentiated adenocarcinoma according to Japanese criteria.

f

Muscular tunic.

HHS Vulnerability Disclosure